Search results for "Standard therapy"

showing 3 items of 3 documents

Noninvasive ventilation in chest trauma: systematic review and meta-analysis

2013

Purpose: Single studies of Noninvasive Ventilation (NIV) in the management of acute respiratory failure in chest trauma patients have produced controversial findings. The aim of this study is to critically review the literature to investigate whether NIV reduces mortality, intubation rate, length of stay and complications in patients with chest trauma, compared to standard therapy. Methods: We performed a systematic review and meta-analysis of randomized controlled trials, prospective and retrospective observational studies, by searching PubMed, EMBASE and bibliographies of articles retrieved. We screened for relevance studies that enrolled adults with chest trauma who developed mild to sev…

AdultRiskmedicine.medical_specialtyThoracic Injuriesmedicine.medical_treatmentMEDLINEChest traumaAcute respiratory failureCritical Care and Intensive Care MedicineAnesthesiologyIntubation IntratrachealmedicineHumansIntubationMeta-analysiIn patientAcute respiratory failureHospital MortalityIntensive care medicineOutcomeNoninvasive VentilationThoracic Injuriebusiness.industryLength of StayTreatment OutcomeMeta-analysisNoninvasive ventilationRespiratory InsufficiencybusinessStandard therapyHumanIntensive Care Medicine
researchProduct

Final results of OV16, a phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel (CP) versus CP in first-line chemoth…

2013

5502 Background: Topotecan was evaluated in a novel combination regimen in comparison to standard therapy in front-line EOC. Methods: Women with newly diagnosed advanced EOC stages IIB-IV, ECOG performance status (PS) 0-1, age < 75, were randomized to either Arm 1: cycles 1 - 4: cisplatin 50 mg/m2 d1 plus topotecan 0.75 mg/m2 d1-5 IV; cycles 5 - 8: paclitaxel 175 mg/m2over 3 hrs d1 followed by carboplatin AUC5 day 1 or Arm 2: paclitaxel plus carboplatin as in Arm 1 for 8 cycles. The primary endpoint was progression free survival (PFS) and secondary endpoints included objective response, overall survival (OS), adverse event (AE) and Quality of Life (QoL). The sample size required 800 pts…

GynecologyOncologyCancer Researchmedicine.medical_specialtybusiness.industryCarboplatin/paclitaxellaw.inventionRegimenOncologyRandomized controlled triallawCisplatin/topotecanInternal medicinemedicineTopotecanEpithelial ovarian cancerFirst line chemotherapybusinessStandard therapymedicine.drugJournal of Clinical Oncology
researchProduct

Water and Sodium in Heart Failure: A Spotlight on Congestion.

2014

Despite all available therapies, the rates of hospitalization and death from heart failure (HF) remain unacceptably high. The most common reasons for hospital admission are symptoms related to congestion. During hospitalization, most patients respond well to standard therapy and are discharged with significantly improved symptoms. Post-discharge, many patients receive diligent and frequent follow-up. However, rehospitalization rates remain high. One potential explanation is a persistent failure by clinicians to adequately manage congestion in the outpatient setting. The failure to successfully manage these patients post-discharge may represent an unmet need to improve the way congestion is …

medicine.medical_specialtySettore MED/09 - Medicina InternaSodium dietPost dischargeDietaryContext (language use)Cardiorespiratory Medicine and HaematologyCardiovascularKidneyUnmet needsBody WaterClinical ResearchCardio-Renal SyndromeOutpatient settingmedicineHumansFluid intakePost-dischargeIntensive care medicineDiureticsOutcomeHeart FailureCardio-Renal Syndromebusiness.industrySodiumSodium Dietarymedicine.diseasePrognosisPatient DischargeManagementHospitalizationHeart DiseaseCardiovascular System & HematologyHeart failureHospital admissionCongestionSymptom AssessmentCardiology and Cardiovascular MedicinebusinessStandard therapyBiomarkersHeart failure Congestion Post-discharge Fluid intake Sodium diet Management Outcome
researchProduct